Color Health today announced findings from its second annual survey, conducted by The Harris Poll. The survey explores how benefits leaders navigate decision-making regarding cancer ...
ALY-101 is an intradermal injectable JAK1 siRNA-lipid conjugate for the treatment of Alopecia Areata Significant progress made in advancing the Alys pipeline following ...
Financing led by CARMA FUND and RV Invest with participation of High-Tech Gründerfonds and others Akribion is pioneering a unique, RNA-guided, nuclease-based technology ...
The Gala, on February 6th, will benefit Glaucoma Research Foundation (GRF) research and patient education programs and honor leaders in glaucoma research and the visionaries who s ...
A global pharmaceutical company partnered with DelveInsight to create a robust and simplified solution enabling its top executives to monitor the evolving breast cancer competitive intelligence ...